UK's Genus soars on US FDA nod for gene-edited pigs

Britain's Genus GNS.L jumps nearly 30% to 2,055p; top gainer on FTSE mid-cap index .FTMC

The animal genetics firm says U.S. FDA approves PRP (PRRS resistant pig) gene edit for use in the U.S. food supply chain

"US approval is crucial in moving to commercialisation, so this is a seminal moment for Genus," Peel Hunt analysts say

Including session's gains, stock up ~25% YTD